A D I van Asselt1, C D Dirksen, A Arntz, J H Giesen-Bloo, J L Severens. 1. Department Of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. thea.van.asselt@mumc.nl
Abstract
INTRODUCTION:Borderline Personality Disorder (BPD) is a severe psychiatric disorder and is associated with significant impairment in quality of life. The aim of the present study is to assess the internal and external responsiveness of the EuroQoL-5D (EQ-5D) in BPD patients. PATIENTS AND METHODS: Data from 49 patients included in a multi-center Dutch randomized trial were used. We used both the EQ-5D utility score and the Visual Analogue Scale of the EuroQoL, and the Borderline Personality Disorder Severity Index-IV (BPDSI-IV). To determine internal responsiveness, we calculated the standardized response mean (SRM). To determine external responsiveness, we calculated Spearman correlations for the change scores, and compared EQ-5D scores for clinically improved vs. non-clinically improved patients as measured with the BPDSI-IV. RESULTS:Patient scores improved on all instruments during the three years. SRMs for BPDSI-IV were significantly higher than EQ-5D utility. Three-year Spearman correlation between change scores of BPDSI-IV and EQ-5D utility was 0.487, between BPDSI-IV and EQ-VAS it was 0.404, both statistically significant. EQ-5D utility scores for patients who clinically improved were significantly higher than for patients who did not. DISCUSSION: We conclude that the EQ-5D is fairly responsive in BPD, and, therefore, especially because of its brevity and user-friendliness, can serve as a useful tool in economic evaluations in patients with BPD.
RCT Entities:
INTRODUCTION: Borderline Personality Disorder (BPD) is a severe psychiatric disorder and is associated with significant impairment in quality of life. The aim of the present study is to assess the internal and external responsiveness of the EuroQoL-5D (EQ-5D) in BPD patients. PATIENTS AND METHODS: Data from 49 patients included in a multi-center Dutch randomized trial were used. We used both the EQ-5D utility score and the Visual Analogue Scale of the EuroQoL, and the Borderline Personality Disorder Severity Index-IV (BPDSI-IV). To determine internal responsiveness, we calculated the standardized response mean (SRM). To determine external responsiveness, we calculated Spearman correlations for the change scores, and compared EQ-5D scores for clinically improved vs. non-clinically improved patients as measured with the BPDSI-IV. RESULTS:Patient scores improved on all instruments during the three years. SRMs for BPDSI-IV were significantly higher than EQ-5D utility. Three-year Spearman correlation between change scores of BPDSI-IV and EQ-5D utility was 0.487, between BPDSI-IV and EQ-VAS it was 0.404, both statistically significant. EQ-5D utility scores for patients who clinically improved were significantly higher than for patients who did not. DISCUSSION: We conclude that the EQ-5D is fairly responsive in BPD, and, therefore, especially because of its brevity and user-friendliness, can serve as a useful tool in economic evaluations in patients with BPD.
Authors: Mike J Crawford; Rahil Sanatinia; Barbara Barrett; Sarah Byford; Gillian Cunningham; Kavi Gakhal; Geof Lawrence-Smith; Verity Leeson; Fenella Lemonsky; Georgia Lykomitrou; Alan Montgomery; Richard Morriss; Carol Paton; Wei Tan; Peter Tyrer; Joseph G Reilly Journal: Trials Date: 2015-07-18 Impact factor: 2.279
Authors: Elisabeth M P Laurenssen; Maaike L Smits; Dawn L Bales; Dine J Feenstra; Hester V Eeren; Marc J Noom; Maartje A Köster; Zwaan Lucas; Reinier Timman; Jack J M Dekker; Patrick Luyten; Jan J V Busschbach; Roel Verheul Journal: BMC Psychiatry Date: 2014-11-18 Impact factor: 3.630
Authors: Nick Verhaeghe; Delphine De Smedt; Jan De Maeseneer; Lea Maes; Cornelis Van Heeringen; Lieven Annemans Journal: BMC Public Health Date: 2014-08-18 Impact factor: 3.295
Authors: Elisabeth M P Laurenssen; Hester V Eeren; Martijn J Kikkert; Jaap Peen; Dieuwertje Westra; Jack J M Dekker; Jan J V Busschbach Journal: Health Qual Life Outcomes Date: 2016-10-12 Impact factor: 3.186
Authors: Elisabeth M P Laurenssen; Dieuwertje Westra; Martijn J Kikkert; Marc J Noom; Hester V Eeren; Anna J van Broekhuyzen; Jaap Peen; Patrick Luyten; Jan J V Busschbach; Jack J M Dekker Journal: BMC Psychiatry Date: 2014-05-22 Impact factor: 3.630
Authors: S D M van Dijk; M S Veenstra; R Bouman; J Peekel; D H Veenstra; P J van Dalen; A D I van Asselt; M L Boshuisen; S P J van Alphen; R H S van den Brink; R C Oude Voshaar Journal: BMC Psychiatry Date: 2019-01-15 Impact factor: 3.630